Episode 20: The Role of Complement in Kidney Diseases
Update: 2025-09-03
Description
Why does it matter if a kidney disease is complement-driven or complement-associated?
Dr. Matthew Pickering (Imperial College London, United Kingdom) explains this critical distinction and why it changes how clinicians approach diagnosis and treatment. The discussion explores promising new therapies such as C3 and C5 inhibitors and how biomarkers are paving the way for precision medicine in nephrology.
This episode is part of a four-part KDIGO Conversations in Nephrology series on complement-mediated kidney diseases, hosted by Dr. Carla Nester (University of Iowa Stead Family Children’s Hospital, United States).
This series was supported by Apellis and Sobi.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
